Hostname: page-component-848d4c4894-p2v8j Total loading time: 0.001 Render date: 2024-06-05T19:19:59.909Z Has data issue: false hasContentIssue false
  • English
  • Français

Acute psychosis after injection of pegylated interferon alpha-2a

Published online by Cambridge University Press:  16 April 2020

J. Thome  and
U. Knopf
J. Thome*
Affiliation:
Central Institute of Mental Health, University of Heidelberg, Mannheim, Germany
U. Knopf
Affiliation:
Central Institute of Mental Health, University of Heidelberg, Mannheim, Germany
*
*E-mail address: thome@zi-mannheim.de

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letter to the editor
Information
European Psychiatry , Volume 18 , Issue 3 , May 2003 , pp. 142 - 143
Copyright
Copyright © Éditions scientifiques et médicales Elsevier SAS 2003

References

Barnard, DL. Pegasys (Hoffmann-La Roche).Curr Opin Investig Drugs 2001;2:1530–8.Google Scholar
Debien, C, De Chouly De Lenclave, MB, Foutrein, P, Bailly, D. Inter-feron alpha et troubles psychiatriques. Encephale 2001;27:308–17.Google Scholar
Zeuzem, S, Heathcote, JE, Martin, N, Nieforth, K, Modi, M. Peginter-feron alfa-2a (40 kDa) monotherapy: a novel agent for chronic hepatitis C therapy. Expert Opin Investig Drugs 2001;10:2201–13.Google Scholar
Submit a response

Comments

No Comments have been published for this article.